• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动与心肌梗死风险:一项全国范围内倾向评分匹配研究。

Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study.

机构信息

Division of Cardiology, Yonsei University College of Medicine, Seoul, Korea.

Division of Cardiology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

出版信息

Sci Rep. 2017 Oct 5;7(1):12716. doi: 10.1038/s41598-017-13061-4.

DOI:10.1038/s41598-017-13061-4
PMID:28983076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5629219/
Abstract

In addition to being an established complicating factor for myocardial infarction (MI), recent studies have revealed that atrial fibrillation (AF) increased risk of MI. This study is to evaluate the risk of MI associated with AF in a nationwide population based cohort. We examine the association between AF and incident MI in 497,366 adults from the Korean National Health Insurance Service database, who were free of AF and MI at baseline. AF group (n = 3,295) was compared with propensity matched no-AF group (n = 13,159). Over 4.2 years of follow up, 137 MI events occurred. AF was associated with 3-fold increased risk of MI (HR, 3.1; 95% CI, 2.22-4.37) in both men (HR, 2.91; 95% CI 1.91-4.45) and women (HR, 3.52; 95% CI 2.01-6.17). The risk of AF-associated MI was higher in patients free of hypertension, diabetes, ischemic stroke, and dyslipidemia at baseline. The cumulative incidence of AF-associated MI was lower in patients on anticoagulant and statin therapies. Our finding suggests that AF complications beyond stoke should extend to total mortality to include MI.

摘要

除了是心肌梗死(MI)的既定并发症外,最近的研究还表明,心房颤动(AF)增加了 MI 的风险。本研究旨在评估在全国人群队列中,AF 与 MI 相关的风险。我们检查了来自韩国国家健康保险服务数据库的 497366 名成年人中 AF 与新发 MI 之间的关联,这些人在基线时无 AF 和 MI。AF 组(n=3295)与倾向评分匹配的无 AF 组(n=13159)进行比较。在 4.2 年的随访期间,发生了 137 例 MI 事件。在男性(HR,2.91;95%CI,1.91-4.45)和女性(HR,3.52;95%CI,2.01-6.17)中,AF 与 MI 风险增加 3 倍相关。在基线时无高血压、糖尿病、缺血性卒中和血脂异常的患者中,AF 相关 MI 的风险更高。在接受抗凝和他汀类药物治疗的患者中,AF 相关 MI 的累积发生率较低。我们的发现表明,AF 并发症除了中风外,还应扩展到包括 MI 的总死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/f7704c6a4ab8/41598_2017_13061_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/e92044886974/41598_2017_13061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/8c2bb0e182ca/41598_2017_13061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/b03d92594196/41598_2017_13061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/d9b10c644738/41598_2017_13061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/f7704c6a4ab8/41598_2017_13061_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/e92044886974/41598_2017_13061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/8c2bb0e182ca/41598_2017_13061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/b03d92594196/41598_2017_13061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/d9b10c644738/41598_2017_13061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9b4/5629219/f7704c6a4ab8/41598_2017_13061_Fig5_HTML.jpg

相似文献

1
Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study.心房颤动与心肌梗死风险:一项全国范围内倾向评分匹配研究。
Sci Rep. 2017 Oct 5;7(1):12716. doi: 10.1038/s41598-017-13061-4.
2
Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.他汀类药物可降低首次心肌梗死人群新发房颤的发生率:一项全国性倾向评分匹配研究。
Eur J Prev Cardiol. 2014 Mar;21(3):330-8. doi: 10.1177/2047487312462804. Epub 2012 Sep 25.
3
Atrial fibrillation and the risk of myocardial infarction.心房颤动与心肌梗死风险。
JAMA Intern Med. 2014 Jan;174(1):107-14. doi: 10.1001/jamainternmed.2013.11912.
4
Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.心房颤动与ST段抬高型心肌梗死和非ST段抬高型心肌梗死风险:社区动脉粥样硬化风险(ARIC)研究
Circulation. 2015 May 26;131(21):1843-50. doi: 10.1161/CIRCULATIONAHA.114.014145. Epub 2015 Apr 27.
5
Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation.在抗凝治疗下,初诊阵发性与非阵发性心房颤动个体的心肌梗死和缺血性卒中风险。
Europace. 2023 Jun 2;25(6). doi: 10.1093/europace/euad143.
6
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.心肌梗死后和冠状动脉介入治疗后的心房颤动患者的口服抗凝和抗血小板治疗。
J Am Coll Cardiol. 2013 Sep 10;62(11):981-9. doi: 10.1016/j.jacc.2013.05.029. Epub 2013 Jun 7.
7
Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.老年房颤患者抗凝治疗后心肌梗死和血管死亡的发生率:与动脉粥样硬化危险因素的关系。
Chest. 2015 Jun;147(6):1644-1650. doi: 10.1378/chest.14-2414.
8
Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)中基线及随访期间的心房颤动。
J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. doi: 10.1016/j.jacc.2009.08.020.
9
Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.华法林治疗与心肌梗死风险——一项针对基层医疗保健中接受治疗的房颤患者的队列研究。
Int J Cardiol. 2016 Oct 15;221:789-93. doi: 10.1016/j.ijcard.2016.07.119. Epub 2016 Jul 9.
10
Resting heart rate predicts incident myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: the Tromsø Study.静息心率可预测普通人群中心梗、房颤、缺血性卒中和死亡的发生:特罗姆瑟研究。
J Epidemiol Community Health. 2016 Sep;70(9):902-9. doi: 10.1136/jech-2015-206663. Epub 2016 Mar 7.

引用本文的文献

1
Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry-Based Case-Control Study.糖尿病并发症和合并症作为2型糖尿病患者发生主要不良心血管事件的危险因素及其随时间的发展:一项基于丹麦登记处的病例对照研究。
J Diabetes. 2025 Mar;17(3):e70076. doi: 10.1111/1753-0407.70076.
2
Mendelian randomization reveals plasminogen as a common therapeutic target for myocardial infarction and atrial fibrillation.孟德尔随机化研究表明,纤溶酶原是心肌梗死和心房颤动的共同治疗靶点。
J Cardiovasc Thorac Res. 2024;16(4):249-257. doi: 10.34172/jcvtr.33269. Epub 2024 Dec 23.
3

本文引用的文献

1
Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.心房颤动与心肌梗死风险增加相关:一项荟萃分析的见解
Atherosclerosis. 2016 Nov;254:1-7. doi: 10.1016/j.atherosclerosis.2016.09.011. Epub 2016 Sep 10.
2
Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.队列简介:韩国国民健康保险服务国家样本队列(NHIS-NSC)
Int J Epidemiol. 2017 Apr 1;46(2):e15. doi: 10.1093/ije/dyv319.
3
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.
The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.
脂肪肝指数和代谢综合征与心血管结局、肝脏相关死亡率及全因死亡率的关联:一项全国性队列研究
Intern Emerg Med. 2025 Jan;20(1):105-117. doi: 10.1007/s11739-024-03758-6. Epub 2024 Sep 5.
4
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).心房心肌病再探——概念的演变:欧洲心脏病学会心律协会 (EHRA)、心律学会 (HRS)、亚太心律学会 (APHRS) 和拉丁美洲心律学会 (LAHRS) 的临床共识声明。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae204.
5
Long-term outcomes after hospitalization for atrial fibrillation or flutter.心房颤动或房扑住院治疗后的长期结局。
Eur Heart J. 2024 Jun 28;45(24):2133-2141. doi: 10.1093/eurheartj/ehae204.
6
Prevalence and Impact of Concomitant Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction.急性心肌梗死患者接受经皮冠状动脉介入治疗时合并心房颤动的患病率及影响
J Clin Med. 2024 Apr 17;13(8):2318. doi: 10.3390/jcm13082318.
7
Atrial fibrillation: comorbidities, lifestyle, and patient factors.心房颤动:合并症、生活方式及患者因素。
Lancet Reg Health Eur. 2024 Feb 1;37:100784. doi: 10.1016/j.lanepe.2023.100784. eCollection 2024 Feb.
8
Associations between clinical and social factors and anticoagulant prescription among patients with atrial fibrillation: A retrospective cohort study from a large healthcare system.临床和社会因素与心房颤动患者抗凝药物处方之间的关联:来自大型医疗保健系统的回顾性队列研究。
PLoS One. 2023 Aug 10;18(8):e0289708. doi: 10.1371/journal.pone.0289708. eCollection 2023.
9
Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data.节律控制策略的成本效益:基于真实世界数据比较韩国房颤治疗中导管消融与抗心律失常药物的效果
Front Cardiovasc Med. 2023 Jan 24;10:1062578. doi: 10.3389/fcvm.2023.1062578. eCollection 2023.
10
The Impact of Cardiac Comorbidity Sequence at Baseline and Mortality Risk in Type 2 Diabetes Mellitus: A Retrospective Population-Based Cohort Study.2型糖尿病患者基线时心脏合并症序列与死亡风险的关系:一项基于人群的回顾性队列研究
Life (Basel). 2022 Nov 22;12(12):1956. doi: 10.3390/life12121956.
年龄对房颤患者中风风险的影响:来自台湾的全国队列研究。
J Am Coll Cardiol. 2015 Sep 22;66(12):1339-47. doi: 10.1016/j.jacc.2015.07.026.
4
Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.心房颤动与ST段抬高型心肌梗死和非ST段抬高型心肌梗死风险:社区动脉粥样硬化风险(ARIC)研究
Circulation. 2015 May 26;131(21):1843-50. doi: 10.1161/CIRCULATIONAHA.114.014145. Epub 2015 Apr 27.
5
Background and data configuration process of a nationwide population-based study using the korean national health insurance system.一项利用韩国国民健康保险系统进行的全国性基于人群研究的背景与数据配置过程。
Diabetes Metab J. 2014 Oct;38(5):395-403. doi: 10.4093/dmj.2014.38.5.395. Epub 2014 Oct 17.
6
Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study.CHA2DS2-VASc评分为0或1的房颤患者急性心肌梗死:一项全国性队列研究
Heart Rhythm. 2014 Nov;11(11):1941-7. doi: 10.1016/j.hrthm.2014.08.003. Epub 2014 Aug 5.
7
Atrial fibrillation and the risk of myocardial infarction.心房颤动与心肌梗死风险。
JAMA Intern Med. 2014 Jan;174(1):107-14. doi: 10.1001/jamainternmed.2013.11912.
8
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.初发心房颤动的健康女性的死亡风险和心血管事件。
JAMA. 2011 May 25;305(20):2080-7. doi: 10.1001/jama.2011.659.
9
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project.心房颤动和心房扑动患者的预后和指南一致的抗血栓治疗:真实临床实践中治疗不足和过度治疗的影响;卢瓦尔河谷心房颤动项目。
Chest. 2011 Oct;140(4):911-917. doi: 10.1378/chest.10-2436. Epub 2011 Mar 24.
10
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?华法林预防卒中血栓栓塞是否能预防房颤患者的 MI?
Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23.